- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Patient-Derived Xenograft Model Market is expected to reach US$ 975.31 million by 2030
Feb 06, 2024
Autoimmune Diseases: Prevalence, Diagnosis, and Treatment Advances
Feb 10, 2026
Pharmaceutical Waste Disposal and Management Market is expected to reach US$ 6,377.95 million by 2030
Jan 10, 2024
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020
OTC Drug and Dietary Supplement Market In-depth Research Analysis By The Insight Partners
Jan 05, 2021
NORTH AMERICA DRY EYE PRODUCT MARKET IS ANTICIPATED TO GROW WITH A CAGR OF 5.0% FROM 2019 TO 2027 , according to Business Market Insights
Jan 28, 2021
AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate
Jul 15, 2020
Follow us on
